Skip to content
- Genetic testing in privately insured women with surgically treated breast cancer.
- Dinan MA, Pitafi S, Greenup RA, Long JB, Gross CP.
- Breast Cancer Res Treat. 2022 Dec 21. doi: 10.1007/s10549-022-06829-4. Epub ahead of print.
- CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carcinoma to PARP inhibitors.
- Lu X, He Y, Johnston RL, Nanayakarra D, Sankarasubramanian S, Lopez JA, Friedlander M, Kalimutho M, Hooper JD, Raninga PV, Khanna KK.
- J Exp Clin Cancer Res. 2022 Dec 21;41(1):355. doi: 10.1186/s13046-022-02570-4.